Intrathecal Topotecan as Part of Retinoblastoma Treatment

被引：0
|
作者：
Sampor, C. [1 ]
Correa Llanos, M. G. [2 ]
Oller, A. [1 ]
Fandino, A. [3 ]
Schaiquevich, P. [4 ]
Aschero, R. [5 ]
Torbidoni, A. [6 ]
Salvador, N. [7 ]
Alderete, D. [1 ]
Chantada, G. [1 ]
机构：
[1] Hosp Pediat Prof Dr JP Garrahan, Hematol & Oncol, Buenos Aires, DF, Argentina
[2] Hosp St Joan de Deu, Hematol & Oncol, Barcelona, Spain
[3] Hosp Pediat Prof Dr JP Garrahan, Ophthalmol, Buenos Aires, DF, Argentina
[4] Hosp Pediat Prof Dr JP Garrahan, Clin Pharmacokinet Unit, Buenos Aires, DF, Argentina
[5] Hosp Pediat Prof Dr JP Garrahan, Pathol, Buenos Aires, DF, Argentina
[6] Consejo Nacl Invest Cient & Tecn, Natl Sci & Tech Res Council, Buenos Aires, DF, Argentina
[7] Hosp St Joan de Deu, Mol Oncol, Barcelona, Spain
来源：
PEDIATRIC BLOOD & CANCER | 2019年 / 66卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
FP130 SIOP
引用
收藏
页码：S74 / S75
页数：2
相关论文
共 50 条
  • [1] Prophylactic Intrathecal Topotecan in the Treatment of Advanced Retinoblastoma Preliminary Report
    Leal-Leal, C.
    Perez-Serrano, A.
    Bosch-Canto, V.
    Garcia-Vicera, X.
    PEDIATRIC BLOOD & CANCER, 2019, 66 : S383 - S384
  • [2] Efficacy of Intrathecal Topotecan in Patients with Advanced Retinoblastoma. Preliminary Report
    Leal, C.
    Perez, A.
    Pena, H.
    PEDIATRIC BLOOD & CANCER, 2017, 64 : S275 - S275
  • [3] Topotecan and Cyclophosphamide as Salvage Therapy in the Treatment of Retinoblastoma
    Cui, Qi
    Aivaliotis, Vasiliki
    O'Brien, Joan
    Stewart, Paul
    INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 2013, 54 (15)
  • [4] Subconjunctival topotecan in fibrin sealant in the treatment of transgenic murine retinoblastoma
    Tsui, Janet Y.
    Dalgard, Clifton
    Van Quill, Kurtis R.
    Lee, Linda
    Grossniklaus, Hans E.
    Edelhauser, Henry F.
    O'Brien, Joan M.
    INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 2008, 49 (02) : 490 - 496
  • [5] Subconjunctival Carboplatin and Systemic Topotecan Treatment in Preclinical Models of Retinoblastoma
    Nemeth, Katie M.
    Federico, Sara
    Carcaboso, Angel M.
    Shen, Ying
    Schaiquevich, Paula
    Zhang, Jiakun
    Egorin, Merrill
    Stewart, Clinton
    Dyer, Michael A.
    CANCER, 2011, 117 (02) : 421 - 434
  • [6] Commentary: Periocular topotecan for retinoblastoma
    Sharma, Minal
    Khetan, Vikas
    INDIAN JOURNAL OF OPHTHALMOLOGY, 2018, 66 (12) : 1838 - 1839
  • [7] Periocular Topotecan for Intraocular Retinoblastoma
    Mallipatna, Ashwin C.
    Dimaras, Helen
    Chan, Helen S. L.
    Heon, Elise
    Gallie, Brenda L.
    ARCHIVES OF OPHTHALMOLOGY, 2011, 129 (06) : 738 - 745
  • [8] Case Report: Successful treatment of metastatic retinoblastoma with CNS involvement with anti-GD2 immunotherapy, intrathecal topotecan and reduced systemic chemotherapy
    Larrosa, Cristina
    Simao-Rafael, Margarida
    Salvador, Noelia
    Munoz, Juan Pablo
    Lavarino, Cinzia
    Chantada, Guillermo
    Mora, Jaume
    FRONTIERS IN PEDIATRICS, 2025, 12
  • [9] Ocular and systemic toxicity of intravitreal topotecan in rabbits for potential treatment of retinoblastoma
    Buitrago, Emiliano
    Del Sole, Maria Jose
    Torbidoni, Ana
    Fandino, Adriana
    Asprea, Marcelo
    Croxatto, J. O.
    Chantada, Guillermo L.
    Bramuglia, Guillermo F.
    Schaiquevich, Paula
    EXPERIMENTAL EYE RESEARCH, 2013, 108 : 103 - 109
  • [10] The Addition of Topotecan to Melphalan in the Treatment of Retinoblastoma with Intra-arterial Chemotherapy
    Stacey, Andrew W.
    De Francesco, Sonia
    Borri, Melissa
    Hadjistilianou, Theodora
    OPHTHALMOLOGY RETINA, 2021, 5 (08): : 824 - 830
12345